Leidos Holdings, Inc. filings document the regulatory record for a NYSE-listed government technology and mission-solutions contractor. The company’s reports and 8-K filings cover operating and financial results, segment reporting, material-event disclosures, capital-structure matters and NYSE common stock registration information.
Leidos filings also include proxy governance and shareholder voting materials, executive compensation disclosures, credit-facility agreements, acquisition disclosures and exhibits tied to press releases, financial statements and material agreements. These documents describe the company’s reporting structure, governance practices, financing arrangements and corporate transactions.
Leidos Holdings director Gregory R. Dahlberg reported new equity awards. He received 1,067 shares of Leidos common stock on May 8, 2026 as a grant with no cash paid per share. After this award, he directly holds 24,036 common shares.
On the same date, he was also granted stock options for 1,281 shares of common stock at an exercise price of $131.2600 per share. According to the footnote, these options vest and become exercisable in full on the earlier of the first anniversary of the grant date or the conclusion of the next annual meeting of stockholders.
Leidos Holdings director David G. Fubini received new equity compensation. On May 8, 2026, he was granted 1,067 shares of common stock at no cost, increasing his direct holdings to 17,547.8435 shares. He was also awarded stock options for 1,281 shares at an exercise price of $131.26 per share.
The options relate to common stock and will vest and become exercisable in full on the earlier of the first anniversary of the grant date or the date the next annual meeting of stockholders is concluded. These Form 4 entries reflect compensation-related acquisitions rather than open-market purchases or sales.
Leidos Holdings, Inc. director Noel B. Geer reported new equity compensation awards. On 2026-05-08, Geer received a grant of 1,067 shares of Common Stock, bringing his directly held common stock to 44,273.8435 shares.
He was also granted stock options for 1,281 shares of Common Stock at an exercise price of $131.2600 per share, which vest in full on the earlier of the first anniversary of the grant date or the conclusion of the next annual stockholders’ meeting. In addition, indirect holdings include 32,000 shares held by a family trust and 2,000 shares held by his spouse.
Leidos Holdings, Inc. director Tina W. Jonas reported equity awards on Common Stock. She received 1,067 shares of Common Stock as a grant with no cash paid per share, increasing her direct holdings to 2,446 shares after the transaction.
She also received a stock option for 1,281 shares of Common Stock with an exercise price of $131.26 per share. The option vests and becomes exercisable in full on the earlier of the first anniversary of the grant date or the conclusion of the next annual stockholder meeting, and expires in 2033. Following this grant, she holds 1,281 stock options directly.
Leidos Holdings director Harry M. Jansen Kraemer Jr. reported new equity awards in the company. He received 1,067 shares of Common Stock indirectly through the Key Executive Stock Deferral Plan, recorded as an acquisition rather than an open-market purchase.
He was also granted 1,281 stock options with a $131.26 exercise price, each convertible into one share of common stock. According to the award terms, the option vests in full on the earlier of the first anniversary of the grant date or the conclusion of the next annual stockholders’ meeting.
Following these transactions, Kraemer holds 93,281 shares of Common Stock directly and 130,472.1669 shares indirectly through the deferral plan, along with the newly granted 1,281 stock options.
Leidos Holdings director Gary Stephen May reported equity grants as compensation. He received 1,067 shares of common stock at no cost, bringing his direct holdings to 11,204 shares. He was also awarded options on 1,281 shares at an exercise price of $131.26 per share.
The stock options vest and become exercisable in full on the earlier of the first anniversary of the grant date or the conclusion of the next annual stockholder meeting, and expire in 2033. These are routine director compensation awards rather than open-market purchases or sales.
Leidos Holdings director Nancy A. Norton reported new equity awards. On May 8, 2026, she received 1,067 shares of Leidos common stock as a stock award at no cash cost, increasing her direct holdings to 3,144 shares.
She was also granted stock options for 1,281 shares of common stock with an exercise price of $131.26 per share. According to the footnote, these options vest and become exercisable in full on the earlier of the first anniversary of the grant date or the date the next annual meeting of stockholders is concluded, and they expire on May 7, 2033.
Leidos Holdings director Patrick M. Shanahan reported routine equity compensation. On May 8, 2026, he received a grant of 1,067 shares of Leidos common stock at no cost, increasing his direct holdings to 5,762 shares.
He was also granted a stock option covering 1,281 shares of common stock at an exercise price of $131.26 per share. According to the footnote, this option vests and becomes exercisable in full on the earlier of the first anniversary of the grant date or the conclusion of the company’s next annual stockholder meeting.
Leidos Holdings director Robert S. Shapard reported new equity awards. He received 1,067 shares of common stock as a grant or award, bringing his directly held common stock to 60,027.08 shares. He also received a stock option for 1,281 shares at an exercise price of $131.26 per share.
The option vests and becomes exercisable in full on the earlier of the first anniversary of the grant date or the conclusion of the company’s next annual stockholder meeting, and expires on May 7, 2033. In addition, he reports 2,500 shares held indirectly through a family limited partnership and 1,624.9954 shares held indirectly through a Key Executive Stock Deferral Plan. The filing shows acquisitions via compensation grants rather than open-market buying or selling.
Leidos Holdings, Inc. director Gary Stephen May exercised stock options and made related share transactions. On May 7, 2026, he exercised options for 3,345 shares of common stock at $75.02 per share. In connection with this exercise, 1,861 shares were withheld by the company to cover the exercise price and associated fees, and he conducted an open-market sale of 1,484 shares at a weighted average price of $132.7528 per share. After these transactions, he directly owned 10,137 shares of Leidos common stock.